E.U. Probes Boston Scientific, Abbott Over Guidant Bids

Law360, New York (March 3, 2006, 12:00 AM EST) -- The European Commission has initiated an antitrust investigation into medical device maker Boston Scientific Corp.’s $27-billion takeover bid for heart device maker Guidant Corp.

Also under review by the Commission is a portion of the acquisition deal involving Abbott Laboratories.

The Commission says it will hand down decisions on both aspects of the investigation by the end of the month.

Rather than treating the cases as simplified merger procedures, the Commission may decide to launch an in-depth investigation if the cases are found to raise competition...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.